Immuno-genomics and cancer

Dr. Ido Amit, Department of Immunology

Prof. Ido Amit pioneered single cell genomic technologies and their application to the characterization of the immune system. Answering some of the most fundamental questions in immunology, his research is being translated into innovate new immunotherapy targets for in the treatment of autoimmune diseases, neurodegeneration and cancer. Prof. Amit is also known in the science community as a leader in the field of immunogenomics, a discipline geared toward detecting and engineering genome sequences that are essential for the function of the immune system in physiology and disease. Among other honors, Prof Amit is a recipient of the EMBO Gold Medal award, and an HHMI International Research Scholar for his work to reveal the function of the immune system.